NO981950L - Sukker-substituerte 2-azetidinener som er anvendbare som hypokolesterolemiske midler - Google Patents

Sukker-substituerte 2-azetidinener som er anvendbare som hypokolesterolemiske midler

Info

Publication number
NO981950L
NO981950L NO981950A NO981950A NO981950L NO 981950 L NO981950 L NO 981950L NO 981950 A NO981950 A NO 981950A NO 981950 A NO981950 A NO 981950A NO 981950 L NO981950 L NO 981950L
Authority
NO
Norway
Prior art keywords
azetidines
sugar
substituted
useful
hypocholesterolemic agents
Prior art date
Application number
NO981950A
Other languages
English (en)
Other versions
NO311692B1 (no
NO981950D0 (no
Inventor
Nathan P Yumibe
Kevin B Alton
Margaret Van Heek
Harry R Davis
Wayne D Vaccaro
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26677904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO981950(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO981950D0 publication Critical patent/NO981950D0/no
Publication of NO981950L publication Critical patent/NO981950L/no
Publication of NO311692B1 publication Critical patent/NO311692B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19981950A 1995-10-31 1998-04-29 Sukkersubstituerte 2-azetidinoner som er anvendbare som hypokolesterolemiske midler NO311692B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US818595P 1995-10-31 1995-10-31
US57084795A 1995-12-12 1995-12-12
PCT/US1996/016823 WO1997016455A1 (en) 1995-10-31 1996-10-29 Sugar-substituted 2-azetidinones useful as hypocholesterolemic a gents

Publications (3)

Publication Number Publication Date
NO981950D0 NO981950D0 (no) 1998-04-29
NO981950L true NO981950L (no) 1998-06-26
NO311692B1 NO311692B1 (no) 2002-01-07

Family

ID=26677904

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19981950A NO311692B1 (no) 1995-10-31 1998-04-29 Sukkersubstituerte 2-azetidinoner som er anvendbare som hypokolesterolemiske midler

Country Status (28)

Country Link
EP (1) EP0877750B1 (no)
JP (2) JP3385031B2 (no)
KR (1) KR100311554B1 (no)
CN (1) CN1103780C (no)
AR (1) AR004701A1 (no)
AT (1) ATE219495T1 (no)
AU (1) AU712158B2 (no)
BR (2) BR9611401B1 (no)
CA (1) CA2235943C (no)
CY (1) CY2353B1 (no)
CZ (1) CZ293957B6 (no)
DE (1) DE69621952T2 (no)
DK (1) DK0877750T3 (no)
ES (1) ES2175141T3 (no)
GE (1) GEP20033006B (no)
HK (1) HK1012507A1 (no)
HU (1) HU226822B1 (no)
ID (1) ID16177A (no)
IL (1) IL124268A (no)
MX (1) MX9803447A (no)
MY (1) MY114803A (no)
NO (1) NO311692B1 (no)
NZ (1) NZ321766A (no)
PL (1) PL184698B1 (no)
PT (1) PT877750E (no)
SK (1) SK283552B6 (no)
TW (1) TW448181B (no)
WO (1) WO1997016455A1 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633246A (en) * 1994-11-18 1997-05-27 Schering Corporation Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
DE10042447A1 (de) * 2000-08-29 2002-03-28 Aventis Pharma Gmbh Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports
NZ525722A (en) * 2000-12-20 2004-11-26 Schering Corp Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
EP1510521A1 (en) * 2000-12-20 2005-03-02 Schering Corporation Sugar-substituted 2-Azetidinones useful as hypocholesterolemic agents
JP4605990B2 (ja) * 2000-12-21 2011-01-05 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 新規な１，２−ジフェニルアゼチジノン、その調製方法、その化合物を含む薬剤、および脂質代謝障害を治療するためのその使用
AU2005246926B2 (en) * 2001-01-26 2008-02-28 Merck Sharp & Dohme Corp. The use of substituted azetidinone compounds for the treatment of sitosterolemia
KR20080067717A (ko) * 2001-01-26 2008-07-21 쉐링 코포레이션 스테롤 흡수 억제제와 혈액 조절제를 포함하는 혈관 질환의치료 또는 예방용 약제학적 조성물
SK287746B6 (sk) * 2001-01-26 2011-08-04 Schering Corporation Použitie substituovaných azetidinónových zlúčenín na liečenie sitosterolémie
TWI291957B (en) * 2001-02-23 2008-01-01 Kotobuki Pharmaceutical Co Ltd Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
CZ304929B6 (cs) 2001-03-28 2015-01-28 Merck Sharp & Dohme Corp. Enantioselektivní syntéza azetidinonových meziproduktů
DK1429756T3 (da) * 2001-09-21 2007-03-19 Schering Corp Behandling af xanthoma med azetidinonderivater som sterolabsorptionsinhibitorer
US7671047B2 (en) 2002-06-19 2010-03-02 Sanofi-Aventis Deutschland Gmbh Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
US7176194B2 (en) 2002-06-19 2007-02-13 Sanofi-Aventis Deutschland Gmbh Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
DE10227506A1 (de) * 2002-06-19 2004-01-08 Aventis Pharma Deutschland Gmbh Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
US7176193B2 (en) 2002-06-19 2007-02-13 Sanofi-Aventis Deutschland Gmbh Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
AR040588A1 (es) 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
AR041089A1 (es) 2003-05-15 2005-05-04 Merck & Co Inc Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas
JP2005015434A (ja) 2003-06-27 2005-01-20 Kotobuki Seiyaku Kk 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
EP1522541A1 (en) * 2003-10-07 2005-04-13 Lipideon Biotechnology AG Novel hypocholesterolemic compounds
US20070135357A1 (en) * 2003-10-30 2007-06-14 Sings Heather L Anti-hypercholesterolemic compounds
WO2005061452A1 (en) 2003-12-23 2005-07-07 Astrazeneca Ab Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
US20060211752A1 (en) 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
WO2006116499A1 (en) * 2005-04-26 2006-11-02 Microbia, Inc. 4-biarylyl-1-phenylazetidin-2-one glucuronide derivatives for hypercholesterolemia
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
JP2009512715A (ja) 2005-10-21 2009-03-26 ノバルティス アクチエンゲゼルシャフト レニン阻害剤と抗異脂肪血症剤および／または抗肥満症剤の組み合わせ
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
US20080319221A1 (en) 2007-06-22 2008-12-25 Bernd Junker Esters of Pentahydroxyhexylcarbamoyl Alkanoic Acids
DE102007063671A1 (de) 2007-11-13 2009-06-25 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
CA2754384A1 (en) 2009-03-06 2010-09-10 Lipideon Biotechnology Ag Pharmaceutical hypocholesterolemic compositions
CN101993403B (zh) 2009-08-11 2012-07-11 浙江海正药业股份有限公司 氮杂环丁酮类化合物及医药应用
CN103102297A (zh) * 2012-09-28 2013-05-15 北京赛林泰医药技术有限公司 一种新的依折麦布的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3595B (en) * 1993-01-21 1995-12-27 Schering Corp Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
CA2120221A1 (en) * 1993-04-23 1994-10-24 Allan W. Rey N-substituted 2-azetidinones
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents

Also Published As

Publication number Publication date
BR9612998B1 (pt) 2010-03-23
EP0877750B1 (en) 2002-06-19
NZ321766A (en) 1999-07-29
HUP9802539A2 (hu) 1998-11-30
SK283552B6 (sk) 2003-09-11
SK48398A3 (en) 1998-11-04
DK0877750T3 (da) 2002-07-15
MX9803447A (es) 1998-09-30
CN1205707A (zh) 1999-01-20
KR19990067202A (ko) 1999-08-16
CN1103780C (zh) 2003-03-26
ATE219495T1 (de) 2002-07-15
DE69621952T2 (de) 2003-01-16
CA2235943A1 (en) 1997-05-09
WO1997016455A1 (en) 1997-05-09
GEP20033006B (en) 2003-07-10
JP2001048895A (ja) 2001-02-20
NO311692B1 (no) 2002-01-07
HU226822B1 (en) 2009-11-30
PL327987A1 (en) 1999-01-04
JP3385031B2 (ja) 2003-03-10
HK1012507A1 (en) 1999-08-06
PL184698B1 (pl) 2002-12-31
BR9611401A (pt) 1999-01-05
ES2175141T3 (es) 2002-11-16
NO981950D0 (no) 1998-04-29
CZ293957B6 (cs) 2004-08-18
KR100311554B1 (ko) 2002-06-20
CA2235943C (en) 2002-10-01
PT877750E (pt) 2002-09-30
DE69621952D1 (de) 2002-07-25
IL124268A (en) 2005-08-31
AU712158B2 (en) 1999-10-28
AR004701A1 (es) 1999-03-10
CZ129498A3 (cs) 1998-10-14
HUP9802539A3 (en) 1999-12-28
BR9611401B1 (pt) 2010-08-10
ID16177A (id) 1997-09-11
AU7517996A (en) 1997-05-22
EP0877750A1 (en) 1998-11-18
CY2353B1 (en) 2004-06-04
MY114803A (en) 2003-01-31
JPH10512592A (ja) 1998-12-02
TW448181B (en) 2001-08-01

Similar Documents

Publication Publication Date Title
NO981950D0 (no) Sukker-substituerte 2-azetidinener som er anvendbare som hypokolesterolemiske midler
BR9607097A (pt) Novos compostos
BR9600534A (pt) Novos compostos
NO980368L (no) Hammer
NO982566D0 (no) Forbindelser
DE69626087D1 (de) Dichtmasse
DE69620348D1 (de) Hammermechanismus
DE69612311D1 (de) Notizblock
TR199501065A2 (tr) Hipokolesterolemik antiateroskleroz ajanlar olarak faydali spirostanil glikosidal kristaller.
DE69610862D1 (de) Notizblock
DE59608566D1 (de) Rektoskop
DE59602637D1 (de) Heftvorrichtung
DE59602899D1 (de) Notizblock
KR970030797U (ko) 변속기 조작기구
KR970012350U (ko) 해머
FI953583A0 (fi) Delningskniv som flyttar stycken som skall saogas laengre ut fraon skaeret
FI944788A0 (fi) Skidstav som foeljer roerelse
FIU950183U0 (fi) Faerdiggraeddad matsporation avsedd att foertaeras som engaongsportion
KR960037856U (ko) 에어콘 겸용 선풍기
FI950875A0 (fi) Mekanism
KR960033361U (ko) 아이라쉬 기구
FI960262A0 (fi) Stoedanordning som foerbaettrar kryckkaeppars och spatserkaeppars hanterbarhet
KR960029344U (ko) 온돌 판넬
NO953640D0 (no) Panel
KR960026733U (ko) 쑥뜸구

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP AND DOHME CORP

Free format text: NEW ADDRESS: 126 EAST LINCOLN AVENUE, US-NJ07065 RAHWAY, US

MM1K Lapsed by not paying the annual fees